Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
B. Asuquo, N. Chandrappa (Coventry, United Kingdom). Audit on the use of T spot test in the diagnosis of active tuberculosis in UHCW. Eur Respir J 2009; 34: Suppl. 53, 2570

Member's Comments

No comment yet.

Related content which might interest you: Using results of new laboratory test for tuberculosis infection in children Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Clinical and demographic characteristics of the tuberculin skin test positive patients without active tuberculosis contact Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013 Experience of skin test application using tuberculosis recombinant allergen (Diaskintest) in tuberculosis diagnostics of children Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015 Positive predictive value of an interferon-gamma release assay for progression from latent to active tuberculosis in new-entrant screening Source: International Congress 2014 – Tuberculosis epidemiology: novel features Year: 2014 Use of quantiFERON-TB goldÔ blood test as first step for immigrant tuberculosis screening in a UK city Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease Year: 2008 Characteristics of the new cases of the tuberculosis according to the method of screening Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013 Safety of two step tuberculin skin test (TST) in the screening of healthcare workers for latent TB infection (LTBI) Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Interpretation of indeterminate RIF-susceptibility results obtained by rapid molecular diagnostics test Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 Clinical utility of the quantiFERON TB-2G test for elderly patients with active tuberculosis Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease Year: 2008 Active tuberculosis cases in migrants in Newham: should we extend screening criteria for latent tuberculosis infection Source: International Congress 2017 – Migrants and screening Year: 2017 Comparison of tuberculin test and Diaskintest® in the diagnosis of tuberculosis in children Source: Annual Congress 2013 –Diagnostic features of tuberculosis II Year: 2013 Usefulness of a daignostic method of tuberculosis infection, QuantiFERON TB-2G, in a contact investigation of medical staffs Source: Eur Respir J 2006; 28: Suppl. 50, 139s Year: 2006 Cartridge based nucleic acid amplification technique (CBNATT) for diagnosis of rifampicin resistance from sputum smear in revised national tuberculosis control of India (RNTCP) – Implications of preliminary data Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013 Outcomes of early interferon-gamma release assay (IGRA) testing in recent contacts of smear positive pulmonary tuberculosis (TB) Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013 Functional and memory status of M. tuberculosis specific T-cells in HIV-infected patients naïve to antiretroviral treatment Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014 A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014 The changing indications for IGRA testing and impact on TB services in a UK district general hospital Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection Year: 2013 Estimation of the role of the test GeneXpert MTB-RIF in the diagnosis of pulmonary tuberculosis Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 CD27 expression as a new tool to distinguish active tuberculosis from latent infection Source: International Congress 2015 – Science and biomarkers in TB Year: 2015 New guidelines for screening for tuberculosis and latent tuberculosis infection pre-immunosuppressive therapy in the Netherlands: a targeted and stratified approach Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019